FEM1C
Basic information
Region (hg38): 5:115520908-115544775
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEM1C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 0 | 1 |
Variants in FEM1C
This is a list of pathogenic ClinVar variants found in the FEM1C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-115524469-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
5-115524595-C-T | not specified | Uncertain significance (Sep 27, 2024) | ||
5-115524636-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
5-115524700-G-A | Benign (Jun 29, 2018) | |||
5-115524749-C-A | not specified | Uncertain significance (Sep 04, 2024) | ||
5-115524756-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
5-115524865-C-G | not specified | Uncertain significance (Jan 31, 2022) | ||
5-115524870-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
5-115524916-A-G | not specified | Uncertain significance (Aug 12, 2024) | ||
5-115525024-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
5-115525059-T-C | Uncertain significance (Oct 10, 2022) | |||
5-115525090-T-C | not specified | Uncertain significance (Sep 27, 2022) | ||
5-115525150-A-C | not specified | Uncertain significance (Jul 30, 2024) | ||
5-115525189-T-C | Neurodevelopmental disorder | Uncertain significance (Oct 10, 2024) | ||
5-115525234-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
5-115525320-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
5-115525440-T-C | not specified | Uncertain significance (Apr 29, 2022) | ||
5-115525452-G-C | not specified | Uncertain significance (Aug 14, 2024) | ||
5-115525477-T-C | not specified | Uncertain significance (Apr 17, 2023) | ||
5-115525528-C-T | not specified | Uncertain significance (Oct 26, 2024) | ||
5-115543054-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
5-115543118-C-G | Neurodevelopmental disorder | Likely pathogenic (Oct 10, 2024) | ||
5-115543118-C-T | Uncertain significance (Oct 11, 2022) | |||
5-115543188-C-A | FEM1C-related condition | Uncertain significance (May 09, 2024) | ||
5-115543270-T-C | not specified | Uncertain significance (Nov 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEM1C | protein_coding | protein_coding | ENST00000274457 | 2 | 23984 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.629 | 0.370 | 125651 | 0 | 7 | 125658 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.43 | 212 | 338 | 0.628 | 0.0000168 | 4082 |
Missense in Polyphen | 42 | 135.89 | 0.30907 | 1644 | ||
Synonymous | 0.404 | 121 | 127 | 0.954 | 0.00000662 | 1213 |
Loss of Function | 3.04 | 3 | 16.2 | 0.185 | 8.58e-7 | 232 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000616 | 0.0000615 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable component of an E3 ubiquitin-protein ligase complex, in which it may act as a substrate recognition subunit. {ECO:0000250}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.365
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.628
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.544
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.932
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fem1c
- Phenotype
Gene ontology
- Biological process
- protein ubiquitination;post-translational protein modification
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- protein binding